Agarose electrophoresis (Isopal, Beckman) and an immunoradiometric assay (IRMA) involving specific monoclonal antibodies (Ostase, Hybritech), two methods for the quantification of serum bone alkaline phosphatase (ALP, EC 3.1.3.1), a marker of osteoblastic activity, were com- 
low bone ALP activities, electrophoresis remains the method of choice. The two major and clinically most relevant isoforms in human serum are bone and liver ALP, formed through posttranslational modifications of the tissue-nonspecific gene product. They mainly circulate in soluble dimeric forms (Sol-liver and Sol-bone ALP). In some conditions, hydrophobic isoforms can be detected as well: anchor-bearing (Anch-) bone ALP in healthy children and adolescents and in subjects with bone disease, and membrane-bound (Mem-) liver ALP in cholestatic liver disease (5) . Bone ALP activity is present on the plasma membrane of osteoblasts and bone matrix vesicles (6 
Materials and Methods

Samples and Patients
Results
For the electrophoretic procedure, total bone ALP and total liver ALP activity were calculated as the sum of Sol-bone and Anch-bone ALP, and of Sol-liver ALP and Mem-liver ALP, respectively. Bone and liver ALP did not correlate at all when they were both determined with the electrophoretic method (r = 0.07, P = 0.3347).
After standardizing our results for both methods by computing z-scores and & (z08+ -Ziw,pai) for bone ALP, a highly significant correlation was found between S.z and total liver ALP activity (r = 0.73, b n as in Table 1 . #{176} P = 0.0000. d 0.0000< P <0.0500. Goodness of fit of the model. P <0.0001) (Fig. 2) . As can be seen in Fig. 2 , there are 10 samples with a z value <-0. 
Discussion
The patient groups in this study were chosen because they represent two conditions in which bone metabolism is often disturbed, either through stimulation (secondary hyperparathyroidism in renal failure, osteoblastic metastasis in malignant disease) or suppression from zero in the two patient groups, suggesting that #{149} the interference of liver ALP is not even across all concentrations of bone ALP. The difference between the two methods, although highly related to liver ALP activity, is not constant (being present in about half of the patients with liver ALP >110 UIL) and thus cannot be predicted. ,..'
#{149}
As can be seen in Fig. 2, 10 concentratlon,) x 100 -100. The expected bone ALP concentra-+20% to > +600% (Fig. 3) . When bone ALP activity by tlon, was calculated with the regression equation in Table 2 bone ALP. We found that a bone ALP concentration of This hypothesis has also been put forward to explain 5 g/L appears indeed to be indicative of low osteothe varying amount of coprecipitation of liver ALP with blastic activity, because all six samples with these low bone ALP by wheat germ lectin. The latter binds to bone ALP concentration also had low bone ALP activity both N-acetylglucosamine and sialic acid residues, and on electrophoresis. The reverse, however, was not true: the accessibility of either or both of these sugars will A normal or even a high bone ALP concentration with determine the affinity of the lectin for individual the Ostase IRMA did not rule out a low osteoblastic proteins (22 found with the IRMA should be confirmed by electrophoresis to rule out cross-reactivity with liver ALP. The same is true for patients with chronic renal insufficiency being treated with hemodialysis, who are prone to develop liver disease (5) . From the results of this study, we think that electrophoresis should remain the method of choice in diseases characterized by a low osteoblastic activity (e.g., adynamic bone disease).
